Shire $18bn loan oversubscribed in syndication
Pharmaceuticals firm Shire completed the syndication of an $18bn acquisition loan on Friday and will use proceeds to buy rare disease specialist Baxalta.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: